BIO says suit over speed of drug development is threat to innovation and new cures
After the Food and Drug Administration (FDA) approved Gilead’s HIV/AIDS drug in 2001, the firm gained FDA approval for a second drug in 2015. […]
BIO says suit over speed of drug development is threat to innovation and new cures Read More »